Home »

Adherex Announces Completion of Reverse Stock Split and Continuance to British Columbia

RESEARCH TRIANGLE PARK, NC — (Marketwire) — 08/25/11 — Adherex Technologies Inc. (TSX-V: AHX) (PINKSHEETS: ADHXF), a biopharmaceutical company focused on the development of eniluracil and 5-fluorouracil, today announced the completion of the consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidation common share for every eighteen (18) pre-consolidation common shares. The consolidation will reduce the number of shares of the company-s outstanding co


© 2021 88Finance. All Rights Reserved. Log in

- Copyright by LayerMedia

Blogverzeichnis - Blog Verzeichnis bloggerei.de Blog Top Liste - by TopBlogs.de